Coventry BJ - Search Results

1

Therapeutic vaccination immunomodulation: forming the basis of all cancer immunotherapy.

Coventry BJ. Coventry BJ. Ther Adv Vaccines Immunother. 2019 Aug 1;7:2515135519862234. doi: 10.1177/2515135519862234. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 31414074 Free PMC article. Review.

2

Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation.

Coventry BJ, Ashdown ML. Coventry BJ, et al. Cancer Manag Res. 2012;4:137-49. doi: 10.2147/CMAR.S31887. Epub 2012 May 28. Cancer Manag Res. 2012. PMID: 22740774 Free PMC article.

3

The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responses.

Coventry BJ, Ashdown ML. Coventry BJ, et al. Cancer Manag Res. 2012;4:215-21. doi: 10.2147/CMAR.S33979. Epub 2012 Aug 2. Cancer Manag Res. 2012. PMID: 22904643 Free PMC article.

4

Long-term survival in advanced melanoma patients using repeated therapies: successive immunomodulation improving the odds?

Coventry BJ, Baume D, Lilly C. Coventry BJ, et al. Cancer Manag Res. 2015 Apr 29;7:93-103. doi: 10.2147/CMAR.S76163. eCollection 2015. Cancer Manag Res. 2015. PMID: 25995649 Free PMC article.

5

Immune profiling in human breast cancer using high-sensitivity detection and analysis techniques.

Coventry BJ, Weightman MJ, Bradley J, Skinner JM. Coventry BJ, et al. JRSM Open. 2015 Sep 22;6(9):2054270415603909. doi: 10.1177/2054270415603909. eCollection 2015 Sep. JRSM Open. 2015. PMID: 26464809 Free PMC article.

6

Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates.

Ashdown ML, Robinson AP, Yatomi-Clarke SL, Ashdown ML, Allison A, Abbott D, Markovic SN, Coventry BJ. Ashdown ML, et al. Among authors: coventry bj. F1000Res. 2015 Jul 13;4:232. doi: 10.12688/f1000research.6760.1. eCollection 2015. F1000Res. 2015. PMID: 26834979 Free PMC article.

7

Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma.

Coventry BJ, Lilly CA, Hersey P, Michele A, Bright RJ. Coventry BJ, et al. J Immunother Cancer. 2014 Apr 15;2:9. doi: 10.1186/2051-1426-2-9. eCollection 2014. J Immunother Cancer. 2014. PMID: 27437102 Free PMC article.

8

Clinical Response Rates From Interleukin-2 Therapy for Metastatic Melanoma Over 30 Years' Experience: A Meta-Analysis of 3312 Patients.

Bright R, Coventry BJ, Eardley-Harris N, Briggs N. Bright R, et al. Among authors: coventry bj. J Immunother. 2017 Jan;40(1):21-30. doi: 10.1097/CJI.0000000000000149. J Immunother. 2017. PMID: 27875387

9

Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.

Miura JT, Kroon HM, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Mark Smithers B, Coventry BJ, Tyler DS, Thompson JF, Zager JS. Miura JT, et al. Among authors: coventry bj. Ann Surg Oncol. 2019 Aug;26(8):2486-2494. doi: 10.1245/s10434-019-07288-w. Epub 2019 Mar 25. Ann Surg Oncol. 2019. PMID: 30911949 Free PMC article.

10

CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?

Coventry BJ, Ashdown ML, Quinn MA, Markovic SN, Yatomi-Clarke SL, Robinson AP. Coventry BJ, et al. J Transl Med. 2009 Nov 30;7:102. doi: 10.1186/1479-5876-7-102. J Transl Med. 2009. PMID: 19948067 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results